Status:
COMPLETED
Determining The Impact Of Distance Reiki On Patient Reported QOL And Immunity Among Multiple Myeloma Patients
Lead Sponsor:
Mayo Clinic
Conditions:
Multiple Myeloma
Autologous Stem Cell Transplant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research study is being done to determine if Distance Reiki therapy offers a quality of life benefit, and improves immunity compared to patients receiving Sham Distance Reiki therapy or no additi...
Detailed Description
Reiki is a popular complementary medicine modality sought after by patients. This non- intrusive Japanese based therapy centers on the guiding of energy through a Reiki practitioner to the patient whi...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Patients with Multiple Myeloma with stable disease or currently in maintenance therapy
- English Speaking
- Computer and internet access with video conferencing availability
Exclusion
- Evidence of disease relapse at the post-transplant follow up visit
- Patient not returning to Mayo Clinic Rochester for subsequent post-transplant follow up
Key Trial Info
Start Date :
January 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04783038
Start Date
January 27 2021
End Date
August 1 2022
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905